Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06385171 · ClinicalTrials.gov registry record
Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation
A clinical trial of Wrinkle, sponsored by Global Aesthetics.
- Recruiting
- Registry status
- 500
- Enrollment target
- 2
- Study locations
NCT06385171 is a study of Wrinkle that is actively recruiting participants, run by Global Aesthetics. The registered enrollment target is 500 participants, above the 100-participant average among 25 other Wrinkle trials with a reported enrollment target (400% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT06385171, a study of Wrinkle, is actively recruiting participants, sponsored by Global Aesthetics.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 2
- Study locations
Study Summary
A study conducting to see how well a treatment called Botulinum Toxin Type A works for reducing facial wrinkles. The study will help us understand if this treatment is safe and effective for making wrinkles on the face less noticeable.
Conditions Studied
Interventions
- DRUG Botulinum toxin type A
Study Locations (2)
Texas
- Global Aesthetics LLC - Cisco
- Global Aesthetics LLC - Lubbock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-05-22 |
| Est. Completion | 2027-01-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06385171
The ClinicalTrials.gov registry entry for NCT06385171 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 100-participant average among 25 other Wrinkle trials with a reported enrollment target (400% higher). The listed sponsor is Global Aesthetics, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Wrinkle appearing as the primary indexed condition, and to 1 intervention - of which Botulinum toxin type A is the first listed.
NCT06385171 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06385171 about?
NCT06385171 is a clinical study titled "Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation". A study conducting to see how well a treatment called Botulinum Toxin Type A works for reducing facial wrinkles. The study will help us understand if this treatment is safe and effective for making wrinkles on the face less noticeable.
What is the current status of trial NCT06385171?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-05-22. Estimated completion is 2027-01-05.
What conditions does trial NCT06385171 study?
This clinical trial studies the following conditions: Wrinkle.
What interventions are being tested in trial NCT06385171?
The interventions under investigation include: Botulinum toxin type A (DRUG).
Who is sponsoring clinical trial NCT06385171?
This trial is sponsored by Global Aesthetics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06385171 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wrinkle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles
RECRUITING · NA
-
AVAVA MIRIA General Use
RECRUITING · NA
-
Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions
RECRUITING · NA
-
The Effects of Almond on Facial Skin Collagen and Wrinkles
RECRUITING · NA
-
A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment
RECRUITING · NA
-
A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions
ACTIVE NOT RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.